Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN30702519) titled 'Testing a non-invasive brain stimulation device (Nettle™) to reduce symptoms of premenstrual dysphoric disorder' on Oct. 21.
Study Type: Interventional
Study Design:
Allocation: Non-randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Queen Mary University of London
Condition:
Premenstrual dysphoric disorder (PMDD)
Mental and Behavioural Disorders
Intervention:
Participants are allocated in a non-randomised manner to receive either active transcranial direct current stimulation (tDCS) or sham stimulation using Nettle™...